<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30075864</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>04</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1879-0887</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Jul</Month>                        <Day>31</Day>                    </PubDate>                </JournalIssue>                <Title>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</Title>                <ISOAbbreviation>Radiother Oncol</ISOAbbreviation>            </Journal>            <ArticleTitle>A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study).</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">S0167-8140(18)33414-5</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.radonc.2018.07.015</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">Breast-conserving surgery (BCS) and whole breast radiation (RT) with or without endocrine therapy (ET) represent the standard of care for ductal carcinoma in situ (DCIS). The use of adjuvant treatments after surgery is still controversial in this setting. We performed a retrospective multicenter analysis on a series of DCIS patients treated with BCS and adjuvant RT.</AbstractText>                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We collected clinical data from nine Italian centers on 1072 women having a diagnosis of DCIS and treated between 1997 and 2012. We reported on the 5- and 10-year local recurrence (LR) rates, overall survival, and breast cancer specific survival (BCSS) employing the Kaplan-Meier method.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">At a median follow-up of 8.4 years, 67 LR (6.3%) and 47 deaths (4.4%) were observed. LR rates at 5 and 10 years were 3.4% and 7.6%, respectively. BCSS rates at 5 and 10 years were 99.7% and 99.1%, respectively. At univariate regression analysis, postmenopausal state (p = 0.009), estrogen receptor (ER) (p = 0.0001) and progesterone receptor (p = 0.018) positivity and ET (p = 0.006) were inversely correlated with LR. Final surgical margins (FSM) status &lt;1 mm was significantly correlated with higher LR (p = 0.003). At multivariate regression analysis postmenopausal state (p = 0.03), and ER positive (p = 0.045) maintained the significant favorable feature, while FSM &lt;1 mm (p = 0.024) confirmed its negative impact on LR.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our real-life study pointed out the significant favorable prognostic role of postmenopausal state and ER positive status on LR occurrence. FSM &lt;1 mm was significantly correlated to a higher chance to experience LR.</AbstractText>                <CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Meattini</LastName>                    <ForeName>Icro</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Azienda Ospedaliero Universitaria Careggi - University of Florence, Radiation Oncology Unit, Florence, Italy; Clinical Oncology Breast Cancer Group (COBCG), Italy. Electronic address: icro.meattini@unifi.it.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pasinetti</LastName>                    <ForeName>Nadia</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Radiation Oncology Department, Brescia University and Spedali Civili, Brescia, Italy; Clinical Oncology Breast Cancer Group (COBCG), Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Meduri</LastName>                    <ForeName>Bruno</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>University Hospital of Modena, Radiation Oncology Unit, Italy; Clinical Oncology Breast Cancer Group (COBCG), Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>De Rose</LastName>                    <ForeName>Fiorenza</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Radiotherapy and Radiosurgery Department, Humanitas Cancer Center and Research Hospital, Rozzano, Italy; Clinical Oncology Breast Cancer Group (COBCG), Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>De Santis</LastName>                    <ForeName>Maria Carmen</ForeName>                    <Initials>MC</Initials>                    <AffiliationInfo>                        <Affiliation>National Cancer Institute of Milan, Italy; Clinical Oncology Breast Cancer Group (COBCG), Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Franco</LastName>                    <ForeName>Pierfrancesco</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>University of Turin, Department of Oncology - Radiation Oncology, Italy; Clinical Oncology Breast Cancer Group (COBCG), Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lancellotta</LastName>                    <ForeName>Valentina</ForeName>                    <Initials>V</Initials>                    <AffiliationInfo>                        <Affiliation>University of Perugia and Perugia General Hospital, Radiation Oncology Section, Italy; Clinical Oncology Breast Cancer Group (COBCG), Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rossi</LastName>                    <ForeName>Francesca</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Azienda USL Toscana Centro, Radiotherapy Unit, Florence, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Saieva</LastName>                    <ForeName>Calogero</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Desideri</LastName>                    <ForeName>Isacco</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Azienda Ospedaliero Universitaria Careggi - University of Florence, Radiation Oncology Unit, Florence, Italy; Clinical Oncology Breast Cancer Group (COBCG), Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Delli Paoli</LastName>                    <ForeName>Camilla</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Azienda Ospedaliero Universitaria Careggi - University of Florence, Radiation Oncology Unit, Florence, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>D'Angelo</LastName>                    <ForeName>Elisa</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>University Hospital of Modena, Radiation Oncology Unit, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Triggiani</LastName>                    <ForeName>Luca</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Radiation Oncology Department, Brescia University and Spedali Civili, Brescia, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bastiani</LastName>                    <ForeName>Paolo</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Azienda USL Toscana Centro, Radiotherapy Unit, Florence, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Alongi</LastName>                    <ForeName>Filippo</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Sacro Cuore Don Calabria Hospital, Verona, Italy; University of Brescia, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lozza</LastName>                    <ForeName>Laura</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>National Cancer Institute of Milan, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Aristei</LastName>                    <ForeName>Cynthia</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>University of Perugia and Perugia General Hospital, Radiation Oncology Section, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ricardi</LastName>                    <ForeName>Umberto</ForeName>                    <Initials>U</Initials>                    <AffiliationInfo>                        <Affiliation>University of Turin, Department of Oncology - Radiation Oncology, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Scorsetti</LastName>                    <ForeName>Marta</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Radiotherapy and Radiosurgery Department, Humanitas Cancer Center and Research Hospital, Rozzano, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Livi</LastName>                    <ForeName>Lorenzo</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Azienda Ospedaliero Universitaria Careggi - University of Florence, Radiation Oncology Unit, Florence, Italy.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <CollectiveName>Clinical Oncology Breast Cancer Group (COBCG) Investigators</CollectiveName>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>31</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Ireland</Country>            <MedlineTA>Radiother Oncol</MedlineTA>            <NlmUniqueID>8407192</NlmUniqueID>            <ISSNLinking>0167-8140</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Ductal carcinoma in situ</Keyword>            <Keyword MajorTopicYN="N">Multicenter study</Keyword>            <Keyword MajorTopicYN="N">Prognostic factors</Keyword>            <Keyword MajorTopicYN="N">Radiotherapy</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>05</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>17</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>18</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>5</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>5</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>5</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30075864</ArticleId>            <ArticleId IdType="pii">S0167-8140(18)33414-5</ArticleId>            <ArticleId IdType="doi">10.1016/j.radonc.2018.07.015</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>